Featured Research

from universities, journals, and other organizations

Stanford Researchers Make Lung Cancer Finding That Could Vastly Improve Treatment And Outcome

Date:
November 19, 2001
Source:
Stanford University Medical Center
Summary:
Researchers at the Stanford University Medical Center have uncovered a group of genes that could distinguish between different forms of lung cancer. This finding may help doctors predict individual treatment strategies and may someday lead to better lung cancer drugs.

STANFORD, Calif. - Researchers at the Stanford University Medical Center have uncovered a group of genes that could distinguish between different forms of lung cancer. This finding may help doctors predict individual treatment strategies and may someday lead to better lung cancer drugs.

"What this means is that we can distinguish between different types of lung cancers, which was not possible before, and that those differences have clinical consequences," said David Botstein, MD, professor of genetics and senior author on the study, published in the Proceedings of the National Academy of Sciences on Nov. 13.

Doctors currently categorize lung tumors into one of four types: small cell, squamous cell, large cell and adenocarcinoma. When doctors diagnose a small-cell tumor, they can provide a fairly accurate prognosis. But other tumor types, particularly adenocarcinomas, respond very differently to standard treatment.

"Lung adenocarcinomas may appear morphologically similar, however, the patients differ in survival and possibly drug sensitivity," said Mitchell Garber, a post-doctoral student and first author on the paper. "At present, the pathologist cannot determine patient survival for those diagnosed with adenocarcinoma."

Garber thought these differences may arise from gene variations within the tumor. If that's the case, doctors would have an additional tool for distinguishing how tumors will grow, helping to determine the best course of treatment for each patient. "The short-term goal is to know the fingerprint of a tumor that has a poor prognosis," Garber said. "That will give the clinician an incentive to look a little harder within this patient for additional tumors."

To find out whether genetic differences exist between lung tumors, Garber obtained RNA from 67 lung tumor samples and six normal lung samples. RNA is produced by active genes and can be used to identify which genes are being expressed in a given sample. He then exposed the RNA samples to a gene chip - a glass slide dotted with 17,108 human genes. If a sample contained RNA corresponding to a gene on the chip, the RNA would bind to the spot and produce a visible signal. The bigger the signal, the more RNA, and therefore the more gene expression. With this technique, Garber grouped his samples according to those that expressed a similar subset of genes.

In most cases, samples that had been assigned to the same category by light microscopy also fell into the same genetic grouping. The adenocarcinoma samples, however, fell into three distinct genetic subtypes. Patients within those subtypes had different outcomes, so knowing a subtype can give doctors useful information about how the cancer will progress. Patients with a subtype 1 tumor had about 40 percent survival over a five-year period, whereas none of the patients with subtype 3 survived during that same period. All patients with subtype 2 tumors were still alive at the end of the study.

Garber said that tumors in subtypes 1 and 3 were initially diagnosed with different stages of the disease. Those in subtype 3 all had more advanced tumors while those in subtype 1 had less advanced tumors, consistent with the survival rates of the two groups. However, those in subtype 2 had a mixture of more advanced and less advanced tumors. Without the genetic analysis, doctors would not have classified these patients in similar subtypes, nor would they have predicted survival.

Botstein said this ability to distinguish between lung tumors could help doctors target therapy. "For those in the subset lucky enough not to have such serious disease, you may want to consider a much less toxic treatment option," he said.

He noted that while adenocarcinomas account for 30 percent of all lung tumors, they comprise 56 percent of lung samples in this study. He predicts that a larger, more representative trial would uncover similar genetic subtypes within other tumor categories.

In addition to predicting a tumor's seriousness, future drug trials can test the drug's effect in the different genetic subtypes. "A treatment may work on one subtype but not on another," Botstein said. "You could see some application of this sooner rather than later."

Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children's Hospital. For more information, please visit the Web site of the medical center's Office of News and Public Affairs at http://mednews.stanford.edu.


Story Source:

The above story is based on materials provided by Stanford University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Stanford University Medical Center. "Stanford Researchers Make Lung Cancer Finding That Could Vastly Improve Treatment And Outcome." ScienceDaily. ScienceDaily, 19 November 2001. <www.sciencedaily.com/releases/2001/11/011119072349.htm>.
Stanford University Medical Center. (2001, November 19). Stanford Researchers Make Lung Cancer Finding That Could Vastly Improve Treatment And Outcome. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2001/11/011119072349.htm
Stanford University Medical Center. "Stanford Researchers Make Lung Cancer Finding That Could Vastly Improve Treatment And Outcome." ScienceDaily. www.sciencedaily.com/releases/2001/11/011119072349.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com
Lost Brain Cells To Blame For Sleep Problems Among Seniors

Lost Brain Cells To Blame For Sleep Problems Among Seniors

Newsy (Aug. 21, 2014) According to a new study, elderly people might have trouble sleeping because of the loss of a certain group of neurons in the brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins